Cargando…
Teratogenicity with Olanzapine
Olanzapine, a 2(nd) generation antipsychotic, is in use in the clinical practice for nearly a decade and a half now. It is classified as a category C drug with very few reports of its toxic effects on the fetus. In general, the risk benefit analysis warrants its use in pregnancy. We report a case of...
Autores principales: | Prakash, Sathya, Chadda, Rakesh Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959031/ https://www.ncbi.nlm.nih.gov/pubmed/24701021 http://dx.doi.org/10.4103/0253-7176.127266 |
Ejemplares similares
-
Teratogenic Effects of Coadministration of Fluoxetine and Olanzapine on Rat Fetuses
por: Bakhtiarian, Azam, et al.
Publicado: (2014) -
Olanzapine in the Treatment of Refractory Nausea and Vomiting in Palliative Care Settings
por: Gupta, Nishkarsh, et al.
Publicado: (2018) -
Olanzapine-induced Orthostatic Hypotension
por: Jana, Amlan Kusum, et al.
Publicado: (2015) -
Olanzapine-induced Skin Eruptions
por: Chawla, Nishtha, et al.
Publicado: (2017) -
Emphysematous pancreatitis predisposed by Olanzapine
por: Samanta, Sukhen, et al.
Publicado: (2014)